| Trial ID: | L0648 |
| Source ID: | NCT06847139
|
| Associated Drug: |
Zinc Sulfate 50 Mg Tab
|
| Title: |
Effect of Zinc Supplementation on Hyperhomocysteinemia Compared to Follic Acid in CKD Patient on Hemodialysis
|
| Acronym: |
CKD
|
| Status: |
ACTIVE_NOT_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease Requiring Hemodialysis
|
| Interventions: |
DRUG: Zinc Sulfate 50 Mg Tab|DRUG: Folic Acid 5 Mg Oral Tablet
|
| Outcome Measures: |
Primary: change from baseline plasma homocysteine level after intervention, six week |
|
| Sponsor/Collaborators: |
Sponsor: Chittagong Medical College
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
90
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2024-07-01
|
| Completion Date: |
2025-09-30
|
| Results First Posted: |
|
| Last Update Posted: |
2025-02-26
|
| Locations: |
Chittagong Medical College, Chattogram, Bangladesh
|
| URL: |
https://clinicaltrials.gov/show/NCT06847139
|
